Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Ldl-Cholesterol'
Ldl-Cholesterol published presentations and documents on DocSlides.
Abnormalities of LDL metabolism
by briana-ranney
Physiology, pathophysiology and treatments. Under...
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
by min-jolicoeur
NICE –CG 181 Continuum of CVD Risk and its trea...
LDL is causal of atherosclerosis
by morgan
Evidence from . meta-analyses of . Mendelian. . r...
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
0 Circulation and Gas Exchange
by tatyana-admore
The fluid that moves around in the circulatory sy...
Familial Hypercholesterolemia
by pasty-toler
Developed by . Ms. . Shawna . Morrison, Dr. Judit...
협심증 ( 狹心症 )
by lois-ondreau
Kyung Woo Park, MD, PhD, MBA . Seoul National Uni...
Triglycerides and Risk for Atherothrombosis
by briana-ranney
Thomas Dayspring, MD, FACP. Clinical Assistant Pr...
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Risk factors in heart disease
by faustina-dinatale
Optimizing . patient care. William Cromwell, MD, ...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
Update: Lipid Guidelines
by yoshiko-marsland
DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
Diabetes and Dyslipidemia
by danika-pritchard
2013 ACC/AHA Guideline on the. Treatment of Blood...
Protecting the heart and the kidney:
by pressio
Implications from the SHARP trial. Dr. Christina R...
Rational Order of Laboratory Tests in Cardiovascular Diseases
by carneos
Sedighe. . S. adat . Ghorashi. . MD. Family Medic...
Oxidized- Low Density Lipoprotein Level Among Organophosphates (OPs)
by mediumgeneral
Pesticide Exposed Workers. Nor Zamzila Abdullah. ...
A naturally randomized trial evaluating the potential clinical benefit of triglyceride lowering the
by arya
Brian A. . Ference. MD, . MPhil. , . MSc. , John ...
DYSLIPIDEMIA IN DIABETES
by esther
MAHTAB NIROOMAND M.D.. Assistant professor of End...
Statin Side effects Active treatment
by ximena
Control. Relative risk. Absolute Effect. (per thou...
ODYSSEY FH I and II In FH I:
by Aquamarine
From baseline to 24 weeks, the change in . LDL-C: ...
6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828
by gelbero
ApoE genotype can affect:Response to treatment wit...
The role of cholesteryl ester transfer protein TaqIB polymorphism in y
by sophie
Bilal Ilanbey Meral Kayikcioglu Ebru Demirel Sez...
CLINICAL PRACTICE
by mia
USTRALIAN FAMILY Vol. 37, No. 7, July 2008 ichard ...
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 73 NUMBER 1 J
by iris
CHRISTOPHER SIBLEY,MDDepartment of Cardiology,John...
SocietyPositionStatementCanadianCardiovascularSocietyPositionStatement
by elizabeth
CanadianJournalofCardiology34(2018)1553 Receivedfo...
New concepts and guidelines in the management of LDL-c and CV Risk:
by cappi
Need for early intervention. Prof. . Ulf . Landmes...
Putting Your Skills to the Test
by deborah
Which ONE of the following statements regarding th...
Non-obese rheumatoid arthritis patients
by valerie
withlow. low-density lipoprotein have higher coro...
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a me
by priscilla
ApoB. and other lipoproteins. Mendelian randomisa...
Update on Clinical Trials:
by adia
How Will This Affect Practice in the Future?. Pame...
SWL lipid management guideline update- Highlights
by finley
. Pedro Bandeira. Specialist Pharmacist- Cardiov...
High Energy Physics Libraries Webzine Issue November httplibrary
by marina-yarberry
cernchHEPLW5papers5 LDL Landscape Digital Library ...
Pediatric Obesity and Metabolic Syndrome
by cheryl-pisano
Chhavi Agarwal, MD, FAAP, MRCP (UK). Assistant Pr...
The results of the SHARP trial
by stefany-barnette
SHARP: Rationale. Risk of vascular events is high...
Fatty Acid Synthesis
by yoshiko-marsland
Chapter 28, . Stryer. Short Course. Lipoprotein ...
On-Treatment
by lois-ondreau
Analysis. A Multicenter, Double-Blind, Randomized...
Load More...